POP Biotechnologies Secures CEPI Funding to Advance “Plug-and-Play” Vaccine Platform POP Biotechnologies has secured up to $1.5 million in...

Branded Legacy, Inc. (OTC: BLEG) has finalized its acquisition of Bio Legacy Evaluative Group (formerly Menlo Health), marking a...

Idorsia’s hypertension drug, Tryvio (aprocitentan), has been nominated for the prestigious Prix Galien USA award in the “Best Pharmaceutical...

Cosmos Health, a global healthcare group, has initiated purchases of Ethereum (ETH), marking a notable shift in its treasury...

X4 Pharmaceuticals secures $60 million in PIPE financing, marking a strategic inflection point for the rare disease company. This...

Rakovina Therapeutics and Nanopalm are joining forces to develop novel oncology therapeutics, starting with KT-3283, a dual PARP-HDAC inhibitor,...

Inmagene Biopharmaceuticals and Ikena Oncology have finalized their merger, creating Imagenebio, a clinical-stage biotech focused on immunology and inflammatory...

Full Alliance Group, Inc. (FAGI) is establishing a new subsidiary, QUBEE HIVE HOLDINGS, INC., under its Qubitera Holdings arm,...

Agios Pharmaceuticals has secured its first regulatory win for Pyrukynd (mitapivat) in thalassemia, with the Saudi Food and Drug...

BridgeBio Oncology Therapeutics (BBOT) has officially launched on the Nasdaq Global Market under the ticker symbol “BBOT,” following a...